序号 |
CAS |
半岛bd体育手机客户端 名称 |
规格 |
包装 |
参考价格 |
1 |
|
Decamethonium sulfate |
≥98% |
|
询价 |
2 |
90093-40-6 |
Suprastat |
≥98% |
|
询价 |
3 |
1797983-09-5 |
GSK J4 HCl |
≥98% |
|
询价 |
4 |
1222800-79-4 |
ML324 |
≥98% |
|
询价 |
5 |
203192-01-2 |
MN58b |
≥98% |
|
询价 |
6 |
1675203-82-3 |
BMS-200 |
≥98% |
|
询价 |
7 |
1675201-90-7 |
BMS-8 |
≥98% |
|
询价 |
8 |
1675201-83-8 |
BMS-1 |
≥98% |
|
询价 |
9 |
2242952-69-6 |
BMS-986299 |
≥98% |
|
询价 |
10 |
2204289-54-1 |
SHMT-IN-2 HCl |
≥98% |
|
询价 |
11 |
561-56-8 |
Gibberellin A5 |
≥98% |
|
询价 |
12 |
144096-47-9 |
Agistatin D |
≥98% |
|
询价 |
13 |
1452458-70-6 |
FPI-1465 |
≥98% |
|
询价 |
14 |
1170694-29-7 |
RJ-34 |
≥98% |
|
询价 |
15 |
2237957-26-3 |
STAT3-IN-8 |
≥98% |
|
询价 |
16 |
2237955-91-6 |
STAT3-IN-7 |
≥98% |
|
询价 |
17 |
153821-50-2 |
Aquastatin A |
≥98% |
|
询价 |
18 |
1454902-97-6 |
Elevenostat |
≥98% |
|
询价 |
19 |
1205538-83-5 |
Calpinactam |
≥98% |
|
询价 |
20 |
2751721-40-9 |
AZ5576 |
≥98% |
|
询价 |
21 |
2499491-04-0 |
STAT3-IN-10 |
≥98% |
|
询价 |
22 |
1026785-59-0 |
cis-Lomibuvir |
≥98% |
|
询价 |
23 |
126775-74-4 |
Himastatin |
≥98% |
|
询价 |
24 |
2452118-54-4 |
VIM-2-IN-1 |
≥98% |
|
询价 |
25 |
265989-49-9 |
4-Hydroxy Atorvastatin lactone-d5 |
≥98% |
|
询价 |
26 |
265989-45-5 |
4-Hydroxy Atorvastatin-d5 calcium |
≥98% |
|
询价 |
27 |
2130853-04-0 |
Belinostat acid-d5 |
≥98% |
|
询价 |
28 |
2043026-13-5 |
Roxadustat-d5 |
≥98% |
|
询价 |
29 |
1285539-74-3 |
Febuxostat-d7 |
≥98% |
|
询价 |
30 |
1185237-51-7 |
Panobinostat-d4 HCl |
≥98% |
|
询价 |
31 |
265989-50-2 |
Ortho-hydroxy atorvastatin lactone-d5 |
≥98% |
|
询价 |
32 |
2712343-38-7 |
Raltegravir-d4 |
≥98% |
|
询价 |
33 |
1801709-41-0 |
Daclatasvir-d6 |
≥98% |
|
询价 |
34 |
|
Givinostat impurity 1-d10 HCl |
≥98% |
|
询价 |
35 |
1356934-56-9 |
Ertapenem-d4 disodium |
≥98% |
|
询价 |
36 |
|
Pravastatin-13C,d3 sodium |
≥98% |
|
询价 |
37 |
|
LQVTDSGLYRCVIYHPP TFA |
≥98% |
|
询价 |
38 |
|
RAR ligand 1(Ch55-O-C3-carbaldehyde) |
≥98% |
50mg, 100mg, 250mg |
询价 |
39 |
|
PROTAC IAP binding moiety 2 |
≥98% |
50mg, 100mg, 250mg |
询价 |
40 |
|
PROTAC IAP binding moiety 1 |
≥98% |
50mg, 100mg, 250mg |
询价 |
41 |
|
PROTAC BRD9-binding moiety 1 hydrochloride |
≥98% |
50mg, 100mg, 250mg |
询价 |
42 |
|
E3 ligase Ligand-Linker Conjugates 32 hydrochloride |
≥98% |
50mg, 100mg, 250mg |
询价 |
43 |
|
E3 ligase Ligand 1 dihydrochloride |
≥98% |
50mg, 100mg, 250mg |
询价 |
44 |
|
E3 ligase Ligand 13 |
≥98% |
50mg, 100mg, 250mg |
询价 |
45 |
|
CDK9 Antagonist-1 |
≥98% |
50mg, 100mg, 250mg |
询价 |
46 |
|
PROTAC B-Raf degrader 1 |
≥98% |
50mg, 100mg, 250mg |
询价 |
47 |
|
PROTAC CRBN Degrader-1 |
≥98% |
50mg, 100mg, 250mg |
询价 |
48 |
|
PROTAC FAK degrader 1 |
≥98% |
50mg, 100mg, 250mg |
询价 |
49 |
|
PROTAC ER Degrader-2 |
≥98% |
50mg, 100mg, 250mg |
询价 |
50 |
|
PROTAC ERαDegrader-1 |
≥98% |
50mg, 100mg, 250mg |
询价 |
51 |
|
TD-428 |
≥98% |
50mg, 100mg, 250mg |
询价 |
52 |
|
E3 Ligase Ligand-Linker Conjugates 23 TFA |
≥98% |
50mg, 100mg, 250mg |
询价 |
53 |
|
E3 ligase Ligand-Linker Conjugates 15 |
≥98% |
50mg, 100mg, 250mg |
询价 |
54 |
|
E3 ligase Ligand-Linker Conjugates 35 Hydrochlride |
≥98% |
50mg, 100mg, 250mg |
询价 |
55 |
|
E3 ligase Ligand-Linker Conjugates 42 |
≥98% |
50mg, 100mg, 250mg |
询价 |
56 |
|
E3 ligase Ligand-Linker Conjugates 44 |
≥98% |
50mg, 100mg, 250mg |
询价 |
57 |
|
E3 ligase Ligand-Linker Conjugates 46 |
≥98% |
50mg, 100mg, 250mg |
询价 |
58 |
|
E3 ligase Ligand-Linker Conjugates 33 |
≥98% |
50mg, 100mg, 250mg |
询价 |
59 |
|
E3 ligase Ligand-Linker Conjugates 45 |
≥98% |
50mg, 100mg, 250mg |
询价 |
60 |
|
E3 ligase Ligand-Linker Conjugates 30 TFA |
≥98% |
50mg, 100mg, 250mg |
询价 |